• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氢键相互作用对非洛地平从与聚乙烯吡咯烷酮形成的纳米分散体中释放机制的影响。

Effect of hydrogen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone.

作者信息

Karavas Evangelos, Ktistis Georgios, Xenakis Aristotelis, Georgarakis Emmanouel

机构信息

Department of Pharmaceutical Technology, School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, Greece.

出版信息

Eur J Pharm Biopharm. 2006 Jun;63(2):103-14. doi: 10.1016/j.ejpb.2006.01.016. Epub 2006 May 3.

DOI:10.1016/j.ejpb.2006.01.016
PMID:16675209
Abstract

Solid dispersion systems are widely investigated for the dissolution enhancement of poorly water soluble drugs. Nevertheless, very limited commercial use has been achieved due to the poor predictability of such systems caused by the lack of a basic understanding of the dissolution optimization mechanism. In the present study an investigation of the release mechanism is performed for solid dispersion systems composed by polyvinylpyrrolidone (PVP) and felodipine (FEL), based on a correlation of their hydrophilicity with the intensity of interactions. The existing interactions were evaluated by using NMR and UV spectroscopy while molecular simulation techniques were also enabled. It was found that the interactions that take place correspond to the creation of hydrogen bonds. The correlation between the intensity of interactions and the concentration of PVP in the matrix showed a sigmoid function. The interactions are impressively increased for polymer concentration exceeding 75% (w/w). This phenomenon was well explained by using the molecular simulation technique. A similar sigmoid pattern was found for the function between dissolution profiles and polymer concentration in the matrix, indicating that the intensity of interactions promotes the dissolution enhancement. Investigation of the solubility and the particle size distribution of FEL in the binary system appeared to have similar behaviour indicating that the interactions affect the release profile through these two factors. The hydrophilicity of PVP does not significantly affect this enhancement as the contact angle was found to be linear to PVP concentration. Microscopic observation of the dissolution behaviour showed that FEL remains in fine dispersion in aqueous solution, verifying the release mechanism.

摘要

固体分散体系统因能提高难溶性药物的溶出度而得到广泛研究。然而,由于对溶出优化机制缺乏基本了解,这类系统的可预测性较差,因此商业应用非常有限。在本研究中,基于聚乙烯吡咯烷酮(PVP)和非洛地平(FEL)的亲水性与相互作用强度的相关性,对由它们组成的固体分散体系统的释放机制进行了研究。通过核磁共振(NMR)和紫外光谱(UV)评估了现有的相互作用,同时也采用了分子模拟技术。结果发现,发生的相互作用对应于氢键的形成。相互作用强度与基质中PVP浓度之间的相关性呈现出S形函数。当聚合物浓度超过75%(w/w)时,相互作用显著增强。利用分子模拟技术很好地解释了这一现象。在溶出曲线与基质中聚合物浓度之间的函数关系中也发现了类似的S形模式,表明相互作用强度促进了溶出度的提高。对二元体系中非洛地平的溶解度和粒径分布的研究似乎也有类似的行为,表明相互作用通过这两个因素影响释放曲线。由于发现接触角与PVP浓度呈线性关系,PVP的亲水性对这种增强作用没有显著影响。对溶出行为的微观观察表明,非洛地平在水溶液中保持良好的分散状态,验证了释放机制。

相似文献

1
Effect of hydrogen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone.氢键相互作用对非洛地平从与聚乙烯吡咯烷酮形成的纳米分散体中释放机制的影响。
Eur J Pharm Biopharm. 2006 Jun;63(2):103-14. doi: 10.1016/j.ejpb.2006.01.016. Epub 2006 May 3.
2
Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.基于药物的物理状态、粒径分布和药物 - 聚合物相互作用,对亲水性载体中难溶性药物从固体分散体的释放机制进行研究。
Eur J Pharm Biopharm. 2007 Jun;66(3):334-47. doi: 10.1016/j.ejpb.2006.11.020. Epub 2006 Dec 1.
3
Felodipine nanodispersions as active core for predictable pulsatile chronotherapeutics using PVP/HPMC blends as coating layer.以非洛地平纳米分散体为活性核心,使用聚乙烯吡咯烷酮/羟丙基甲基纤维素共混物作为包衣层,用于可预测的脉冲式时辰治疗。
Int J Pharm. 2006 Apr 26;313(1-2):189-97. doi: 10.1016/j.ijpharm.2006.01.015. Epub 2006 Feb 17.
4
Miscibility behavior and formation mechanism of stabilized felodipine-polyvinylpyrrolidone amorphous solid dispersions.稳定型非洛地平-聚乙烯吡咯烷酮无定形固体分散体的混溶行为及形成机制
Drug Dev Ind Pharm. 2005 Jul;31(6):473-89. doi: 10.1080/03639040500215958.
5
Combining SEM, TEM, and micro-Raman techniques to differentiate between the amorphous molecular level dispersions and nanodispersions of a poorly water-soluble drug within a polymer matrix.结合扫描电子显微镜(SEM)、透射电子显微镜(TEM)和显微拉曼技术,以区分聚合物基质中难溶性药物的无定形分子水平分散体和纳米分散体。
Int J Pharm. 2007 Aug 1;340(1-2):76-83. doi: 10.1016/j.ijpharm.2007.03.037. Epub 2007 Mar 30.
6
Dissolution rate enhancement of the poorly water-soluble drug Tibolone using PVP, SiO2, and their nanocomposites as appropriate drug carriers.使用 PVP、SiO2 及其纳米复合材料作为合适的药物载体来提高难溶性药物替勃龙的溶出速率。
Drug Dev Ind Pharm. 2009 Sep;35(9):1128-38. doi: 10.1080/03639040902787653.
7
Dissolution rate and stability study of flavanone aglycones, naringenin and hesperetin, by drug delivery systems based on polyvinylpyrrolidone (PVP) nanodispersions.基于聚乙烯吡咯烷酮(PVP)纳米分散体的药物传递系统对黄烷酮苷元、柚皮素和橙皮苷的溶出速率和稳定性研究。
Drug Dev Ind Pharm. 2010 Mar;36(3):292-301. doi: 10.1080/03639040903140589.
8
Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine.聚合物类型对含非洛地平无定形固体分散体溶出曲线的影响。
Eur J Pharm Biopharm. 2008 Oct;70(2):493-9. doi: 10.1016/j.ejpb.2008.05.023. Epub 2008 Jun 6.
9
Dissolution and precipitation behavior of amorphous solid dispersions.无定形固体分散体的溶解和沉淀行为。
J Pharm Sci. 2011 Aug;100(8):3316-3331. doi: 10.1002/jps.22579. Epub 2011 May 23.
10
Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling.通过喷雾干燥、熔融挤出和球磨法制备三种难溶性药物的玻璃态溶液
Int J Pharm. 2007 May 4;336(1):22-34. doi: 10.1016/j.ijpharm.2006.11.030. Epub 2006 Nov 15.

引用本文的文献

1
Eudragit S 100 Assisted Molecular Solid Dispersion of Andrographolide Tendered Augmented Drug Delivery and Apoptosis in Human Colon Cancer, HT-29 Cells.Eudragit S 100辅助的穿心莲内酯分子固体分散体促进了人结肠癌HT-29细胞中的药物递送增强及细胞凋亡。
AAPS PharmSciTech. 2025 Mar 11;26(3):82. doi: 10.1208/s12249-025-03073-z.
2
Development of raft-forming liquid formulations loaded with ginger extract-solid dispersion for treatment of gastric ulceration.用于治疗胃溃疡的载姜提取物-固体分散体的筏状形成液体制剂的研发。
Heliyon. 2024 May 23;10(11):e31803. doi: 10.1016/j.heliyon.2024.e31803. eCollection 2024 Jun 15.
3
Insights into the Mechanism of Enhanced Dissolution in Solid Crystalline Formulations.
固体结晶制剂中溶出度提高机制的见解
Pharmaceutics. 2024 Apr 7;16(4):510. doi: 10.3390/pharmaceutics16040510.
4
A Comparative Study on Cyclodextrin Derivatives in Improving Oral Bioavailability of Etoricoxib as a Model Drug: Formulation and Evaluation of Solid Dispersion-Based Fast-Dissolving Tablets.以依托考昔为模型药物,比较环糊精衍生物对其口服生物利用度的改善作用:基于固体分散体的速溶片的制备与评价
Biomedicines. 2023 Sep 1;11(9):2440. doi: 10.3390/biomedicines11092440.
5
Biopreservatives against foodborne bacteria: combined effect of nisin and nanoncapsulated curcumin and co-encapsulation of nisin and curcumin.针对食源性病原体的生物防腐剂:乳酸链球菌素与纳米包封姜黄素的联合作用以及乳酸链球菌素与姜黄素的共包封
J Food Sci Technol. 2023 Feb;60(2):581-589. doi: 10.1007/s13197-022-05641-8. Epub 2022 Dec 7.
6
Development of starch/chitosan expandable films as a gastroretentive carrier for ginger extract-loaded solid dispersion.淀粉/壳聚糖可膨胀薄膜作为载有姜提取物固体分散体的胃滞留载体的研发。
Saudi Pharm J. 2022 Feb;30(2):120-131. doi: 10.1016/j.jsps.2021.12.017. Epub 2022 Jan 5.
7
Effect of Surfactants and Polymers on the Dissolution Behavior of Supersaturable Tecovirimat-4-Hydroxybenzoic Acid Cocrystals.表面活性剂和聚合物对超饱和替考韦仑-4-羟基苯甲酸共晶体溶解行为的影响
Pharmaceutics. 2021 Oct 22;13(11):1772. doi: 10.3390/pharmaceutics13111772.
8
Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies.药物非晶态固体分散体:制备策略综述
Acta Pharm Sin B. 2021 Aug;11(8):2505-2536. doi: 10.1016/j.apsb.2021.05.014. Epub 2021 Jun 5.
9
How Does the Addition of KollidonVA64 Inhibit the Recrystallization and Improve Ezetimibe Dissolution from Amorphous Solid Dispersions?加入聚乙烯吡咯烷酮VA64如何抑制重结晶并改善非晶态固体分散体中依折麦布的溶出度?
Pharmaceutics. 2021 Jan 23;13(2):147. doi: 10.3390/pharmaceutics13020147.
10
Compression-Induced Phase Transitions of Bicalutamide.比卡鲁胺的压缩诱导相变
Pharmaceutics. 2020 May 9;12(5):438. doi: 10.3390/pharmaceutics12050438.